866-997-4948(US-Canada Toll Free)

Published on : May 13, 2016

ALBANY, New York, May 13, 2016: The report is an in-depth study of the key dynamics of the market. According to the report, the peripheral artery disease market is expected to witness healthy growth owing to the rising prevalence of unhealthy lifestyles among people across the world. 

The report comprises a market outlook section wherein the market forecast methodology is discussed. Co-relation analysis and regression analysis form an important part of the methodology. The global peripheral artery disease market forecast is presented based on the use of these proven research methodologies. Tables, charts, graphs, and statistics have been used wherever required. The information is presented in a clear and concise manner to provide a better understanding for a reader. 

The report discusses the peripheral artery disease market by value, by volume, by treatment, and by major regions such as the U.S. and Europe. The competitive landscape of the market is discussed by evaluating the leading companies in the global peripheral artery disease market, the global peripheral atherectomy market, and the U.S. peripheral atherectomy market. 

Click here to get more info with TOC in a PDF Format: http://www.researchmoz.us/enquiry.php?type=S&repid=712498

Peripheral artery disease (PAD) is a medical condition in which plaque builds up in the artery walls blocking the flow of oxygen-rich blood to the legs, arms, and stomach. Major factors causing PAD are smoking, abnormal cholesterol levels, diabetes, high blood pressure, a history of vascular disease, and advancing age. The symptoms of peripheral artery disease include weakness, fatigue, numbness, intermittent claudication, and tingling. Ulcers on legs and feet can occur among those with severe peripheral artery disease. Preventing PAD requires a lifelong attempt to adopt a certain lifestyle, which includes adequate physical exercise and healthy eating.

The medical diagnosis of peripheral artery disease includes ultrasounds, angiography, ankle-brachial index, blood tests, and catheter angiography. The treatment can be done using one or a combination of several of the following devices – drug-coated balloons (DCB), percutaneous transluminal angioplasty (PTA), atherectomy, drug-eluting stents, stents, and arterial bypass. 

The global peripheral artery disease market is driven by the rising prevalence of obesity. The growing geriatric population is also favoring the growth of the market. The limitations of peripheral interventions is one of the restrains on the market. Some of the key trends in the global peripheral artery disease market include a rising preference for DCB as a treatment for ISR and favorable reimbursements plans. 

The report profiles some of the leading players in the global peripheral artery disease market for the purpose of study. The business overview, financial overview, and business strategies implemented by each of the companies have been included. The companies studied in the report are: Cardiovascular Systems Inc., Medtronic Plc., Spectranetics Corp., and Boston Scientific Corp.

To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on sales@researchmoz.us